Position in CRSP
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,521,520
+$656,156 QoQ
Shares Held
101,238
-1.0% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#68
of 519 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPITAL INTERNATIONAL SARL holds $261,404,130 across 8 Biotechnology names. CRSP ranks #7 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,718 | $104,669,952 | |
| 2 | RPRX |
Royalty Pharma plc
|
1,076,063 | $60,334,852 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
175,542 | $50,024,203 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
58,080 | $17,483,822 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
25,458 | $15,874,081 | |
| 6 | ASND |
Ascendis Pharma A/S
|
26,222 | $6,993,931 | |
| 7 | CRSP |
CRISPR Therapeutics AG
This page
|
101,238 | $5,521,520 | |
| 8 | CYTK |
Cytokinetics Inc
|
5,890 | $501,769 |
All Filings in CRSP
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,521,520 | 101,238 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $4,865,364 | 102,278 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $4,969,686 | 94,769 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $6,458,770 | 99,657 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,451,386 | 91,517 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $3,503,116 | 102,942 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $7,357,171 | 186,920 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $8,011,170 | 170,523 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $8,068,715 | 149,393 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $9,672,449 | 141,908 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $6,427,392 | 102,674 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,182,370 | 92,143 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,796,320 | 85,435 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,499,535 | 77,372 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,378,716 | 58,517 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,260,768 | 49,897 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,900,824 | 31,279 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,518,343 | 24,189 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $1,527,876 | 20,162 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $439,661 | 3,928 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $680,261 | 4,202 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $727,200 | 5,968 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,552,994 | 10,143 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $793,325 | 9,485 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||